Chris Jacobs bought Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA)
Chris Jacobs (R-NY), a U.S. Representative, has disclosed 2 trades in Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA) since 2020, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Chris Jacobs bought $1,001 - $15,000 of Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA) on December 28, 2020. Since that trade, RETA is up +0.00% against the S&P 500 up +110.55%, an outperformance of -110.55%.
Across these filings, Chris Jacobs has been a balanced trader of RETA (a buy-to-sell ratio of 1.00). The most recent disclosed RETA transaction shown was dated January 4, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Chris Jacobs's RETA trades vs the price
RETA is up +0.00% since Chris Jacobs bought on December 28, 2020, versus +110.55% for the S&P 500.
Performance since this trade
All Chris Jacobs RETA trades
Chris Jacobs & RETA trading FAQ
Is it legal for Chris Jacobs to trade Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Chris Jacobs buy RETA?
Chris Jacobs disclosed a purchase of $1,001 - $15,000 of Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA) on December 28, 2020, according to public STOCK Act filings.
How has RETA performed since Chris Jacobs's trade?
Since Chris Jacobs bought RETA on December 28, 2020, the stock is up +0.00%, versus +110.55% for the S&P 500 over the same period, an outperformance of -110.55%.
How many times has Chris Jacobs traded RETA?
Chris Jacobs has disclosed 2 RETA trades since 2020 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional RETA trades?
Quantellect tracks every disclosed congressional trade in Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] (RETA) on the Reata Pharmaceuticals, Inc. - Class A (RETA) [ST] congressional trading page, which aggregates filings across all members of Congress.
Chris Jacobs's RETA tradesAll congressional filings for Reata Pharmaceuticals, Inc. - Class A (RETA) [ST]Chris Jacobs's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.